Home > Financial Ratios > JAGSONPAL PHARMACEUTICALS

JAGSONPAL PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
JAGSONPAL PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for JAGSONPAL PHARMACEUTICALS
Please provide your vote to see the results

JAGSONPAL PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) -18.9040.1821.22112.252.74

What is the latest Core EBITDA Growth ratio of JAGSONPAL PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of JAGSONPAL PHARMACEUTICALS is -18.90 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar2024-18.90
Mar202340.18
Mar202221.22
Mar2021112.25
Mar20202.74

How is Core EBITDA Growth of JAGSONPAL PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2024 -18.9
Negative
Mar2023 40.18
89.35
Mar2022 21.22
-81.10
Mar2021 112.25
3,996.72
Mar2020 2.74 -

Other Financial Ratios of JAGSONPAL PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of JAGSONPAL PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
JAGSONPAL PHARMACEUTICALS ₹1,881.1 Cr 7.4% 29.5% 85.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,273.0 Cr 1.7% 2% -0.6% Stock Analytics
DIVIS LABORATORIES ₹176,604.0 Cr 0.4% -2% 37.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹126,316.0 Cr 6% 10.5% 13.6% Stock Analytics
CIPLA ₹125,993.0 Cr 6.8% 4.6% -0.5% Stock Analytics
DR REDDYS LABORATORIES ₹107,795.0 Cr 4.2% 1.3% -6.7% Stock Analytics


JAGSONPAL PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
JAGSONPAL PHARMACEUTICALS

7.4%

29.5%

85.9%

SENSEX

-1.5%

-2.5%

0.2%


You may also like the below Video Courses